Jetstream™

Atherectomy System

 

Long Term Outcomes with Jetstream Atherectomy System with or without Drug Coated Balloons in Treating Femoropopliteal Arteries: A Single Center Experience

The JET-SCE1


Objective

The JET-SCE observed the long-term outcomes in treating femoropopliteal arteries with drug coated balloons versus plain old balloon angioplasty post Jetstream™ Atherectomy.

Key Resources

Sign-Up for product Updates
icon-contact-email-update

Request a Sales Rep

 icon-contact-email

Submit Your Questions

Patient and Lesion Characteristics 

Patient Characteristics

  • 81 patients 
  • 49.4% male
  • 68.3 average age
  • 53.1 % diabetic
     

 

Lesion Characteristics

  • 25.9% CTOs
  • 14.9 cm average lesion length in PTA cohort
  • 12.0 cm average lesion length in DCB cohort
     
The JET-SCE included patients with de novo or restenotic femoropopliteal lesions whose symptoms were classified as Rutherford Category I-V 

Results

At 12-months results demonstrated 95.2% freedom from TLR with Jetstream + DCB

Jetstream Device and Procedural Success

  • 87% Device Success (<50% stenosis post Jetstream alone)
  • 94% Procedural Success (<30% residual final treatment)


Patient Procedure Details and Outcomes

  • 12-months: Jetstream + DCB 95.2% freedom from TLR
  • 12-months: Jetstream + PTA 69.8% freedom from TLR
  • 18-months: Jetstream + DCB 91.1% freedom from TLR
  • 18-months: Jetstream + PTA 63.7% freedom from TLR
  • 28 patients received adjunctive DCB
  • 53 patients received adjunctive PTA
     

Minimal Luminal Diameter

  • Baseline: 1.5 mm ± 1.4 mm
  • Post Jetstream: 3.1 mm ± 1.2 mm
  • Post Final Treatment: 4.2 mm ± 0.9 mm
     
Top